Pioglitazone could induce remission in major depression: a meta-analysis

BACKGROUND: Pioglitazone, a selective agonist of the nuclear transcription factor peroxisome proliferator-activated receptor-gamma (PPAR-γ), prescribed for the treatment of type 2 diabetes, could have antidepressant properties. However, its potential to induce remission of major depressive episodes,...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:Neuropsychiatr Dis Treat
Autors principals: Colle, Romain, de Larminat, Delphine, Rotenberg, Samuel, Hozer, Franz, Hardy, Patrick, Verstuyft, Céline, Fève, Bruno, Corruble, Emmanuelle
Format: Artigo
Idioma:Inglês
Publicat: Dove Medical Press 2016
Matèries:
Original Research
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC5182046/
https://ncbi.nlm.nih.gov/pubmed/28031713
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2147/NDT.S121149
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars